Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation

GÜR S., Kadowitz P. J., Hellstrom W. J. G.

EXPERT OPINION ON DRUG SAFETY, cilt.12, sa.1, ss.81-90, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 12 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1517/14740338.2013.742885
  • Dergi Adı: EXPERT OPINION ON DRUG SAFETY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.81-90
  • Anahtar Kelimeler: 5-alpha reductase enzyme, benign prostatic hyperplasia, dutasteride, finasteride, hair loss, human erectile function, BENIGN PROSTATIC HYPERPLASIA, URINARY-TRACT SYMPTOMS, QUALITY-OF-LIFE, 5-ALPHA-REDUCTASE INHIBITOR, COMBINATION THERAPY, TISSUE DISTRIBUTION, PENILE ERECTION, FINASTERIDE, MEN, DUTASTERIDE
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: Treatment with 5-alpha reductase inhibitors (5ARI) is commonly utilized for the treatment of benign prostatic hyperplasia (BPH). The true prevalence of sexual side effects with 5ARI treatment is currently unknown.